Category: Uncategorized
-
BREAKING: Microsoft takes Via LA HEVC patent pool license
Microsoft has joined Via LAâs HEVC (H.265) patent pool as a licensee, bringing an end to standard-essential patent litigation initiated by licensors M&K, Gensquare LLC, and Tagivan II in Germany, the pool administrator announced today.
-
Xiaomiâs IP strategy head Na Wei warns 2025 smartphone market is âflatâ
During a recent speech, Xiaomiâs general manager of corporate business development and IP strategy Na Wei discussed the companyâs IP trajectory so far, the way she believes IP licensing should act as an invisible hand to support the sustainability of the IP system. She also attributes what is now a âflatâ smartphone market to the…
-
BREAKING: Nokia ramps up Paramount video streaming enforcement campaign, sues in UPC, Germany
Nokia has sued Paramount in the Unified Patent Courtâs Mannheim Local District and the Munich I Regional Court over the alleged infringement of three video-related patents.
-
Federal Circuit reverses $166 million damages award: AT&T, Nokia emerge victorious in radio network patent infringement dispute
The Federal Circuit has reversed a district courtâs ruling that had awarded Finesse Wireless LLC $166 million in damages, after finding no infringement of the asserted patents.
-
BYD, IP Bridge settle 4G SEP dispute
Sources close to ip fray have confirmed that IP Bridge has withdrawn its 4G standard-essential patent dispute against the Chinese electric vehicle maker.
-
UPCâs Milan Local Division hears Progress Maschinen v. AWM two years after erroneous dismissal
The UPCâs Milan LD now has to decide a lattice girder welding machine patent case, whereas the defendant claims the alleged infringing machines use technology it had already discovered as far back as 2008 (before the patent-in-suit was issued).Â
-
Unitree Robotics faces its first-ever patent infringement suit as it starts IPO processÂ
A local chemical company has sued Unitree, the worldâs leading robotic dog manufacturer, in Hangzhou, China, over alleged patent infringement, shortly after the company started preparations to file for an IPO.
-
Pharma patent litigation updates: Pfizer faces new COVID UPC suit, Merck and Sun Pharma assert in the UK
Enanta has filed a fresh complaint against Pfizer over its COVID drug Paxlovid in the Unified Patent Court, while Merck has countersued Halozyme over patents related to its injectable drug Keytruda, and Sun Pharma has initiated a new dispute against Incyte in the UK.
-
Federal judge finds Lindis patents unenforceable in leukemia drug dispute, Amgen dodges $50 million payment
The District of Delaware has found two patents asserted in a dispute between Lindis and Amgen over the latterâs leukaemia drug Blincyto âunenforceable due to inequitable conductâ, rendering a prior $50 million jury verdict against Amgen irrelevant.
-

âBeing a decent person is foundation for lasting successâ: outgoing InterDigital IP head
Following her departure from InterDigital last month, Mang Zhu sits down with ip fray to reflect on her time as Head of IP, discuss whatâs next for her, and share what sheâd tell younger women aspiring to get to her position following her decades-long career in SEP licensing.
